Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Grinsztejn, Beatriz"'
Autor:
Perazzo H; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Gonçalves JL; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Cardoso SW; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Veloso VG; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Luz PM; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil. paula.luz@ini.fiocruz.br.
Publikováno v:
AIDS and behavior [AIDS Behav] 2024 Apr; Vol. 28 (4), pp. 1173-1185. Date of Electronic Publication: 2023 Jul 31.
Autor:
Bocage AE; South American Program in HIV Prevention Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. anne_bocage@brown.edu.; The Warren Alpert Medical School of Brown University, 222 Richmond St, Box G-M117, Providence, RI, 02912, USA. anne_bocage@brown.edu., Coelho LE; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Lake JE; South American Program in HIV Prevention Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.; UTHealth Houston, Houston, TX, USA., Clark JL; South American Program in HIV Prevention Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.; Center for HIV Identification, Prevention, and Treatment Services, Department of Family Medicine, University of California Los Angeles, Los Angeles, CA, USA., Torres TS; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Jalil EM; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Cardoso SW; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Moreira RI; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Veloso VG; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Grinsztejn B; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Luz PM; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Publikováno v:
AIDS and behavior [AIDS Behav] 2023 Aug; Vol. 27 (8), pp. 2629-2641. Date of Electronic Publication: 2023 Jan 30.
Autor:
Guillen-Diaz-Barriga C; National Institute of Psychiatry Ramon de la Fuente Muñiz, Col. San Lorenzo Huipulco Alc. Tlalpan, 14370, Mexico City, Mexico., Diaz-Sosa D; National Institute of Psychiatry Ramon de la Fuente Muñiz, Col. San Lorenzo Huipulco Alc. Tlalpan, 14370, Mexico City, Mexico., Torres TS; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil., Konda KA; Universidad Peruana Cayetano Heredia, Lima, Peru., Robles-Garcia R; National Institute of Psychiatry Ramon de la Fuente Muñiz, Col. San Lorenzo Huipulco Alc. Tlalpan, 14370, Mexico City, Mexico., Hoagland B; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil., Benedetti M; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil., Pimenta C; Ministry of Health, Brasilia, DF, Brazil., Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil., Caceres CF; Universidad Peruana Cayetano Heredia, Lima, Peru., Veloso VG; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil., Vega-Ramirez H; National Institute of Psychiatry Ramon de la Fuente Muñiz, Col. San Lorenzo Huipulco Alc. Tlalpan, 14370, Mexico City, Mexico. hamid.vega@gmail.com.
Publikováno v:
AIDS and behavior [AIDS Behav] 2023 Mar; Vol. 27 (3), pp. 992-1002. Date of Electronic Publication: 2022 Sep 19.
Autor:
Guillen-Diaz-Barriga C; National Institute of Psychiatry Ramon de la Fuente Muñiz, Col. San Lorenzo Huipulco Alc. Tlalpan, 14370, Mexico City, Mexico., Diaz-Sosa D; National Institute of Psychiatry Ramon de la Fuente Muñiz, Col. San Lorenzo Huipulco Alc. Tlalpan, 14370, Mexico City, Mexico., Torres TS; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil., Konda KA; Universidad Peruana Cayetano Heredia, Lima, Peru., Robles-Garcia R; National Institute of Psychiatry Ramon de la Fuente Muñiz, Col. San Lorenzo Huipulco Alc. Tlalpan, 14370, Mexico City, Mexico., Hoagland B; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil., Benedetti M; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil., Pimenta C; Ministry of Health, Brasilia, DF, Brazil., Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil., Caceres CF; Universidad Peruana Cayetano Heredia, Lima, Peru., Veloso VG; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil., Vega-Ramirez H; National Institute of Psychiatry Ramon de la Fuente Muñiz, Col. San Lorenzo Huipulco Alc. Tlalpan, 14370, Mexico City, Mexico. hamid.vega@gmail.com.
Publikováno v:
AIDS and behavior [AIDS Behav] 2023 Mar; Vol. 27 (3), pp. 1003.
Autor:
Bezerra DRB; STD/AIDS Clinical Research Lab (LapClin-AIDS), Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Jalil CM; STD/AIDS Clinical Research Lab (LapClin-AIDS), Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Jalil EM; STD/AIDS Clinical Research Lab (LapClin-AIDS), Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Coelho LE; STD/AIDS Clinical Research Lab (LapClin-AIDS), Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Carvalheira E; STD/AIDS Clinical Research Lab (LapClin-AIDS), Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Freitas J; STD/AIDS Clinical Research Lab (LapClin-AIDS), Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Monteiro L; STD/AIDS Clinical Research Lab (LapClin-AIDS), Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Santos T; STD/AIDS Clinical Research Lab (LapClin-AIDS), Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Souza C; STD/AIDS Clinical Research Lab (LapClin-AIDS), Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Hoagland B; STD/AIDS Clinical Research Lab (LapClin-AIDS), Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Veloso VG; STD/AIDS Clinical Research Lab (LapClin-AIDS), Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Grinsztejn B; STD/AIDS Clinical Research Lab (LapClin-AIDS), Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Cardoso SW; STD/AIDS Clinical Research Lab (LapClin-AIDS), Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Torres TS; STD/AIDS Clinical Research Lab (LapClin-AIDS), Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil. thiago.torres@ini.fiocruz.br.
Publikováno v:
AIDS and behavior [AIDS Behav] 2022 Aug; Vol. 26 (8), pp. 2643-2652. Date of Electronic Publication: 2022 Feb 05.
Autor:
Hovhannisyan L; South American Program in HIV Prevention Research (SAPHIR), University of California Los Angeles, Los Angeles, USA. Lyolya.hovhannisyan@gmail.com.; Department of Medicine, Division of Infectious Diseases, David Gefen School of Medicine at UCLA, Los Angeles, USA. Lyolya.hovhannisyan@gmail.com., Coelho LE; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Velasque L; Universidade Federal Do Estado Do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil., De Boni RB; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Clark J; South American Program in HIV Prevention Research (SAPHIR), University of California Los Angeles, Los Angeles, USA.; Department of Medicine, Division of Infectious Diseases, David Gefen School of Medicine at UCLA, Los Angeles, USA., Cardoso SW; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Lake J; South American Program in HIV Prevention Research (SAPHIR), University of California Los Angeles, Los Angeles, USA.; Department of Medicine, Division of Infectious Diseases, McGovern Medical School at University of Texas Health Science Center at Houston (UTHealth), Houston, USA., Veloso VG; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Luz PM; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Publikováno v:
AIDS and behavior [AIDS Behav] 2022 Mar; Vol. 26 (3), pp. 963.
Autor:
Hovhannisyan L; South American Program in HIV Prevention Research (SAPHIR), University of California Los Angeles, Los Angeles, USA. Lyolya.hovhannisyan@gmail.com.; Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, USA. Lyolya.hovhannisyan@gmail.com., Coelho LE; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Velasque L; Universidade Federal do Estado do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil., De Boni RB; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Clark J; South American Program in HIV Prevention Research (SAPHIR), University of California Los Angeles, Los Angeles, USA.; Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, USA., Cardoso SW; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Lake J; South American Program in HIV Prevention Research (SAPHIR), University of California Los Angeles, Los Angeles, USA.; Department of Medicine, Division of Infectious Diseases, McGovern Medical School at University of Texas Health Science Center at Houston (UTHealth) , Houston, USA., Veloso VG; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Luz PM; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Publikováno v:
AIDS and behavior [AIDS Behav] 2022 Mar; Vol. 26 (3), pp. 947-962. Date of Electronic Publication: 2021 Sep 25.
Autor:
Coelho LE; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, INI-Fiocruz. Av. Brasil, 4365 Manguinhos, Rio de Janeiro, RJ, Brazil. lara.coelho@ini.fiocruz.br., Torres TS; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, INI-Fiocruz. Av. Brasil, 4365 Manguinhos, Rio de Janeiro, RJ, Brazil., Veloso VG; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, INI-Fiocruz. Av. Brasil, 4365 Manguinhos, Rio de Janeiro, RJ, Brazil., Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, INI-Fiocruz. Av. Brasil, 4365 Manguinhos, Rio de Janeiro, RJ, Brazil., Jalil EM; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, INI-Fiocruz. Av. Brasil, 4365 Manguinhos, Rio de Janeiro, RJ, Brazil., Wilson EC; Department of Public Health, San Francisco, CA, USA., McFarland W; Department of Public Health, San Francisco, CA, USA.
Publikováno v:
AIDS and behavior [AIDS Behav] 2022 Jan; Vol. 26 (1), pp. 296.
Autor:
Coelho LE; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, INI-Fiocruz. Av. Brasil, 4365 Manguinhos, Rio de Janeiro, RJ, Brazil. lara.coelho@ini.fiocruz.br., Torres TS; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, INI-Fiocruz. Av. Brasil, 4365 Manguinhos, Rio de Janeiro, RJ, Brazil., Veloso VG; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, INI-Fiocruz. Av. Brasil, 4365 Manguinhos, Rio de Janeiro, RJ, Brazil., Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, INI-Fiocruz. Av. Brasil, 4365 Manguinhos, Rio de Janeiro, RJ, Brazil., Jalil EM; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, INI-Fiocruz. Av. Brasil, 4365 Manguinhos, Rio de Janeiro, RJ, Brazil., Wilson EC; Department of Public Health, San Francisco, CA, USA., McFarland W; Department of Public Health, San Francisco, CA, USA.
Publikováno v:
AIDS and behavior [AIDS Behav] 2021 Oct; Vol. 25 (10), pp. 3223-3237. Date of Electronic Publication: 2021 Feb 15.
Autor:
Luz PM; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil. paula.luz@ini.fiocruz.br., Torres TS; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Almeida-Brasil CC; Research Institute of the McGill University Health Centre, Montreal, Canada., Marins LMS; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Veloso VG; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, 21040-900, Brazil., Cox J; Research Institute of the McGill University Health Centre, Montreal, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montreal, Canada., Moodie EEM; Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montreal, Canada.
Publikováno v:
AIDS and behavior [AIDS Behav] 2021 Mar; Vol. 25 (3), pp. 748-757.